Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

874 ARTÍCULOS , VIENDO DEL 406 AL 420

Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care

Techa-Angkoon P, Pitakpatapee Y, Saengphatrachai W, Srivanitchapoom P, Suansanae T.

Int J Clin Pharm. 2025 Jun;47(3):834-843. doi: 10.1007/s11096-025-01883-6. Epub 2025 Feb 13.

Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies

Devos D, Rascol O, Meissner WG, Foubert-Samier A, Lewis S, Tranchant C, Anheim M, Maltête D, Remy P, Eggert K, Pape H, Geny C, Couratier P, Carroll C, Sheridan R, Burn D, Pavese N, Raw J, Berg D, Suchowersky O, Kalia LV, Evans A, Drapier S, Danaila T, Schnitzler A, Corvol JC, Defer G, Temin NT, Fradette C, Tricta F, Moreau C; a Parkinson's disease study group.

J Parkinsons Dis. 2025 Feb;15(1):72-86. doi: 10.1177/1877718X241300295. Epub 2024 Dec 27.

Aging, cellular senescence and Parkinson's disease

Ma Y, Erb ML, Moore DJ.

J Parkinsons Dis. 2025 Mar;15(2):239-254. doi: 10.1177/1877718X251316552. Epub 2025 Feb 2.

Opicapone for Parkinson's disease-related sleep disturbances: The OASIS clinical trial

Ferreira JJ, Gago MF, Costa R, Fonseca MM, Almeida J, Rocha JF, Holenz J, Trenkwalder C.

J Parkinsons Dis. 2025 Feb;15(1):87-96. doi: 10.1177/1877718X241306711. Epub 2025 Jan 17.

Improving reliability of movement assessment in Parkinson's disease using computer vision-based automated severity estimation

Xu J, Xu X, Guo X, Li Z, Dong B, Qi C, Yang C, Zhou D, Wang J, Song L, He P, Kong S, Zheng S, Fu S, Xie W, Liu X, Cao Y, Liu Y, Qiu Y, Zheng Z, Yang F, Gan J, Wu X.

J Parkinsons Dis. 2025 Mar;15(2):349-360. doi: 10.1177/1877718X241312605. Epub 2025 Feb 13.

Cross-evaluation of wearable data for use in Parkinson's disease research: a free-living observational study on Empatica E4, Fitbit Sense, and Oura

Reithe H, Marty B, Torrado JC, Førsund E, Husebo BS, Erdal A, Kverneng SU, Sheard E, Tzoulis C, Patrascu M.

Biomed Eng Online. 2025 Feb 21;24(1):22. doi: 10.1186/s12938-025-01353-0.

Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet

Khowdiary MM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Elhenawy AA, Babalghith AO, Shokr MM, Alexiou A, Papadakis M, El-Saber Batiha G.

Eur J Pharmacol. 2025 May 15;995:177419. doi: 10.1016/j.ejphar.2025.177419. Epub 2025 Feb 21.

Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson's Disease

Marino G, Campanelli F, Natale G, De Carluccio M, Servillo F, Ghiglieri V, Calabresi P.

Curr Neuropharmacol. 2025;23(9):1021-1035. doi: 10.2174/011570159X336597241217062042.

Guidelines for Parkinson's disease management part II: consensus from the movement disorders scientific department of the Brazilian Academy of Neurology - non-motor symptoms

Maia DP, Cury RG, Brandão PRP, Cardoso FEC, Bertholo AP, Felicio AC, Hilbig A, Lobato BLS, Barbosa ERF, Quagliato EMAB, Sousa GHC, Parmera JB, Rúbia M, Coletta MVD, Rocha MSG, Spitz M, Haddad M, Murta NRAF, Caramelli P, Rodrigues RND, Nitrini R, Prado R, Tumas V, Corrêa Neto Y, Saba RA.

Arq Neuropsiquiatr. 2025 Jan;83(1):1-15. doi: 10.1055/s-0045-1802962. Epub 2025 Feb 24.

Thalamic Deep Brain Stimulation Versus Magnetic Resonance-Guided Focused Ultrasound in Tremor Patients: A Retrospective Single-Surgeon Comparison

Baumann CR, Fleisch A, Mahendran S, Uhl M, Freudinger C, Efthymiou E, Oertel MF, Stieglitz LH, Büchele F.

Mov Disord. 2025 May;40(5):834-843. doi: 10.1002/mds.30153. Epub 2025 Feb 27.

Exploration of Neurodegenerative Diseases Using Long-Read Sequencing and Optical Genome Mapping Technologies

Cogan G, Daida K, Blauwendraat C, Billingsley K, Brice A.

Mov Disord. 2025 Jun;40(6):996-1008. doi: 10.1002/mds.30151. Epub 2025 Mar 3.

Targeting the ClpP-αSynuclein Interaction with a Decoy Peptide to Mitigate Neuropathology in Parkinson's Disease Models

Hu D, Sun X, Qi X.

bioRxiv [Preprint]. 2025 Feb 20:2025.02.16.638540. doi: 10.1101/2025.02.16.638540.

Comparative Study of Focused Ultrasound Unilateral Thalamotomy and Subthalamotomy for Medication-Refractory Parkinson's Disease Tremor

Paschen S, Natera-Villalba E, Pineda-Pardo JA, Del Álamo M, Rodríguez-Rojas R, Hensler J, Deuschl G, Obeso JA, Helmers AK, Martínez-Fernández R.

Mov Disord. 2025 May;40(5):823-833. doi: 10.1002/mds.30159. Epub 2025 Mar 3.

Reported Symptoms in Prodromal and Early Motor Parkinson's Disease: A Scoping Review on the Patient Perspective

Saade J, van Wyk A, Stebbins GT, Mestre TA.

Mov Disord Clin Pract. 2025 Jun;12(6):721-733. doi: 10.1002/mdc3.70007. Epub 2025 Mar 3.

Inferior olivary hypertrophy and palatal tremor in cerebrotendinous xanthomatosis

Sharma R, Modi T, Shree R, Ahuja CK.

BMJ Case Rep. 2025 Mar 3;18(3):e262226. doi: 10.1136/bcr-2024-262226.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias